BBIO

BridgeBio Pharma, Inc. is a leading biopharmaceutical company based in Palo Alto, California, focusing on the discovery, development, and commercialization of innovative therapies for genetic diseases and rare disorders. With a robust pipeline and a commitment to addressing critical unmet medical needs, BridgeBio employs advanced scientific methodologies to create transformative treatments. The company’s dedication to improving patient outcomes positions it as a formidable player in the genetic medicine space, with a vision to redefine care standards for underserved patient populations.